HIV-1-Infected Human Macrophages, by Secreting RANK-L, Contribute to Enhanced Osteoclast Recruitment.
HIV-1
RANK-L
bone defects
cell migration
macrophages
osteoclasts
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Apr 2020
30 Apr 2020
Historique:
received:
29
03
2020
revised:
27
04
2020
accepted:
28
04
2020
entrez:
6
5
2020
pubmed:
6
5
2020
medline:
12
2
2021
Statut:
epublish
Résumé
HIV-1 infection is frequently associated with low bone density, which can progress to osteoporosis leading to a high risk of fractures. Only a few mechanisms have been proposed to explain the enhanced osteolysis in the context of HIV-1 infection. As macrophages are involved in bone homeostasis and are critical host cells for HIV-1, we asked whether HIV-1-infected macrophages could participate in bone degradation. Upon infection, human macrophages acquired some osteoclast features: they became multinucleated, upregulated the osteoclast markers RhoE and β3 integrin, and organized their podosomes as ring superstructures resembling osteoclast sealing zones. However, HIV-1-infected macrophages were not fully differentiated in osteoclasts as they did not upregulate NFATc-1 transcription factor and were unable to degrade bone. Investigating whether infected macrophages participate indirectly to virus-induced osteolysis, we showed that they produce RANK-L, the key osteoclastogenic cytokine. RANK-L secreted by HIV-1-infected macrophages was not sufficient to stimulate multinucleation, but promoted the protease-dependent migration of osteoclast precursors. In conclusion, we propose that, by stimulating RANK-L secretion, HIV-1-infected macrophages contribute to create a microenvironment that favors the recruitment of osteoclasts, participating in bone disorders observed in HIV-1 infected patients.
Identifiants
pubmed: 32365752
pii: ijms21093154
doi: 10.3390/ijms21093154
pmc: PMC7246503
pii:
doi:
Substances chimiques
Biomarkers
0
RANK Ligand
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Agence Nationale de la Recherche
ID : ANR16-CE13-0005-01
Organisme : Agence Nationale de Recherches sur le Sida et les Hépatites Virales
ID : ANRS2014-CI-2, ANRS2014-049, ANRS2018-2
Organisme : Fondation de l'Avenir pour la Recherche Médicale Appliquée
ID : FRM DEQ2016 0334894
Organisme : Human Frontier Science Program
ID : RGP0035/2016
Références
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7431-7438
pubmed: 30918127
Ann N Y Acad Sci. 2011 Dec;1240:14-7
pubmed: 22172034
Pflugers Arch. 2017 Apr;469(3-4):517-525
pubmed: 28247013
Science. 2000 Sep 1;289(5484):1504-8
pubmed: 10968780
J Med Virol. 2008 Sep;80(9):1507-14
pubmed: 18649336
Eur J Cell Biol. 2006 Apr;85(3-4):195-202
pubmed: 16546562
Blood. 2015 Mar 5;125(10):1611-22
pubmed: 25527710
Blood. 2004 Dec 15;104(13):4029-37
pubmed: 15308576
Am J Pathol. 2006 Sep;169(3):987-98
pubmed: 16936272
Cell Adh Migr. 2014;8(3):191-204
pubmed: 24714644
J Immunol. 2010 Jan 15;184(2):1049-61
pubmed: 20018633
Curr Treat Options Infect Dis. 2017 Mar;9(1):52-67
pubmed: 28413362
Dev Cell. 2002 Dec;3(6):889-901
pubmed: 12479813
Cell Host Microbe. 2014 Dec 10;16(6):711-21
pubmed: 25467409
J Bone Miner Res. 2017 Mar;32(3):431-433
pubmed: 28177151
Cell Rep. 2019 Mar 26;26(13):3586-3599.e7
pubmed: 30917314
Curr HIV/AIDS Rep. 2012 Mar;9(1):16-25
pubmed: 22179898
Biomaterials. 2019 Mar;196:51-66
pubmed: 29107337
Adv Exp Med Biol. 2007;602:15-21
pubmed: 17966383
Cell Adh Migr. 2014;8(3):179-91
pubmed: 24713854
FASEB J. 2013 Sep;27(9):3608-18
pubmed: 23742809
Mol Biol Cell. 2008 Jan;19(1):394-404
pubmed: 17978100
J Orthop Res. 2013 Feb;31(2):218-26
pubmed: 23281130
Mol Biol Cell. 2014 Feb;25(3):380-96
pubmed: 24284899
J Cell Sci. 2017 Jun 15;130(12):2026-2035
pubmed: 28473470
Nature. 2019 Apr;568(7753):541-545
pubmed: 30971820
J Cell Sci. 2006 Dec 1;119(Pt 23):4878-88
pubmed: 17105771
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2556-E2565
pubmed: 29463701
AIDS. 2003 Sep 5;17(13):1917-23
pubmed: 12960824
Cancer Immunol Res. 2018 Nov;6(11):1337-1351
pubmed: 30181209
Drug Discov Today. 2016 Sep;21(9):1345-1354
pubmed: 27151158
Pharmacol Ther. 2017 Jun;174:43-54
pubmed: 28185913
Retrovirology. 2015 Feb 07;12:12
pubmed: 25809599
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13848-53
pubmed: 20643942
J Med Virol. 2007 Oct;79(10):1446-54
pubmed: 17705184
Nat Commun. 2015 Sep 22;6:8282
pubmed: 26392000
Curr Opin HIV AIDS. 2014 Jan;9(1):17-26
pubmed: 24263798
AIDS. 2018 Apr 24;32(7):885-894
pubmed: 29424771
Nature. 2019 Aug;572(7771):670-675
pubmed: 31391580
Aging Cell. 2015 Aug;14(4):534-46
pubmed: 25847297
ACS Nano. 2017 Apr 25;11(4):4028-4040
pubmed: 28355484
J Bone Miner Metab. 2017 Mar;35(2):234-242
pubmed: 27026434
Curr Osteoporos Rep. 2017 Aug;15(4):385-395
pubmed: 28647885
Eur J Cell Biol. 2006 Apr;85(3-4):203-11
pubmed: 16360241
Nat Microbiol. 2019 Apr;4(4):633-644
pubmed: 30718846
Blood. 2008 Dec 15;112(13):5074-83
pubmed: 18768394
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7070-5
pubmed: 15103018
J Immunol. 2013 Jan 15;190(2):605-12
pubmed: 23241888
J Neuroimmune Pharmacol. 2011 Dec;6(4):658-75
pubmed: 21789505
PLoS Pathog. 2014 Nov 13;10(10):e1004497
pubmed: 25393853
Ann N Y Acad Sci. 2007 Nov;1116:227-37
pubmed: 18083930
Int J Mol Med. 2003 Jan;11(1):17-21
pubmed: 12469211
J Cell Sci. 1995 Dec;108 ( Pt 12):3649-59
pubmed: 8719871
Traffic. 2005 Aug;6(8):682-94
pubmed: 15998323
Bone. 2008 Dec;43(6):976-82
pubmed: 18835590
Front Immunol. 2017 Nov 30;8:1698
pubmed: 29250073
Nat Immunol. 2018 May;19(5):475-486
pubmed: 29670239
Biomed Res Int. 2014;2014:731039
pubmed: 24719884
AIDS. 2010 Sep 10;24(14):2233-8
pubmed: 20616695
Cell Host Microbe. 2016 Mar 9;19(3):304-10
pubmed: 26962941
J Immunol. 2010 Jun 15;184(12):7030-9
pubmed: 20488787